Stressreduction in recent onset schizophrenia

• Conditions: mental disorder with hallucinations and delusions; psychotic disorder; 10039628

• Registration Number: NL-OMON32546
• Lead Sponsor: Academisch Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 12

Inclusion Criteria

age between 18-30, psychotic disorder, distress, PANSS-score under 5

Exclusion Criteria

PANSS-score above 4

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The feasibility of the procedure will be described and drop-out analyses will<br /><br>be made. The outcome will be measured by the Symptom CheckList 90, State and<br /><br>Trait Anxiety Inventory-DY and Mindfulness Questionnaire. Possible (adverse)<br /><br>effects on psychotic symptoms are measured by the Positive And Negative<br /><br>Syndrome Scales.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Possible (adverse) effects on psychotic symptoms are measured by the Positive<br /><br>And Negative Syndrome Scales.</p><br>